Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Research on GHK-Cu by Mulder et al
The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC), those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), individuals with known hypersensitivity to semaglutide or any of the excipients, and those who are pregnant or breastfeeding
The affinity profile is calibrated for triple balance: full agonist at GIPR, full agonist at GLP-1R, partial agonist at GCGR, preserving glycemia while exploiting glucagon thermogenic benefits
Taking 1 mL working solution as an example, add 100 L DMSO stock solution ( 20.8 mg/mL ) to 900 L 20% SBE--CD in Saline, and mix evenly
US$ 28.08
US$ 29.35
US$ 26.67
US$ 28.17
